Webinar
Reproducible Brain Organoids for Reliable CNS Safety Assessment

CNS safety failures during GLP toxicology testing are infrequent, placing the burden of failure on the patient.

Brain organoids offer a promising solution by recapitulating key features of the human cortex—cell sourcing, cellular diversity, and 3D structure—enabling researchers to predict neurotoxicity before clinical trials.

In this on-demand webinar, discover how CNS-3D organoids deliver unparalleled consistency, with reproducible viability, morphology, and electrophysiology across plates and lots.

Discussion Points

CNS-3D mirrors composition and maturity of the human cortex (~50% neurons, ~50% astrocytes), with a representative neuronal mix (~90% excitatory, ~10% inhibitory).

Spontaneous electrophysiological activity provides a sensitive, translational readout for neurotoxicity.

CNS-3D is 7.4x more predictive of human clinical outcomes than animal models and achieves 93.3% specificity.

Uniform size (<1% CV) and standardized biology deliver reproducible results batch-to-batch and year-to-year, enabling routine adoption.